Cingulate Inc. (CING) Balance Sheet

NASDAQ: CINGAssets, liabilities, debt and equity over 7 years.

CING balance sheet, 2025

December 31, 2025 · U.S. dollars

$15.1M assets = $12.6M liabilities + $2.5M equity

What it owns$15.1MCash & ST investments: $11.0M (72.7%)Cash & ST investments$11.0M · 73%Receivables: $8,013 (0.1%)Other current: $1.0M (6.9%)Other current $1.0MPP&E: $3.1M (20.3%)PP&E$3.1M · 20%=How it is financed$15.1MCurrent liabilities: $10.3M (68.4%)Current liabilities$10.3M · 68%Long-term debt: $1.2M (7.6%)Long-term debt $1.2MOther LT liabilities: $1.1M (7.3%)Other LT liabilities $1.1MShareholders’ equity: $2.5M (16.6%)Shareholders’ equity$2.5M · 17%

Both columns are drawn to the same scale: what CING owns equals what it owes plus shareholders’ equity. Hover a block for its value.

CING financial health

Current ratio1.16
Adequate · current assets cover current liabilities 1.16×
Debt / equity3.50
High leverage · $3.50 of debt for each $1 of equity
Equity / assets16.6%
Thin equity · of assets funded by shareholders
Cash / debt124.7%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

CING balance sheet trends, 2019–2025

Cingulate Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$5.3M2019$15.1M2025+19.1%/yr
Total liabilities$4.7M2019$12.6M2025+18.0%/yr
Shareholders’ equity$615,8802019$2.5M2025+26.4%/yr
Cash & short-term investments$437,1932019$11.0M2025+71.1%/yr
Total debt$2.1M2019$8.8M2025+27.0%/yr
Net cash (debt)−$1.7M2019$2.2M2025+$3.8M
Working capital−$2.0M2019$1.7M2025+$3.7M
Book value per share$1.962024$0.462025−76.4%/yr
Current ratio0.3320191.162025+0.83
Debt / equity3.3920193.502025+0.11
Shares outstanding3.8M20245.4M2025+42.5%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

CING assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

CING liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

CING debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

CING balance sheet

Cingulate Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$11.0M$12.2M$52,416$5.4M$16.5M$1.2M$437,193
Cash & equivalents$11.0M$12.2M$52,416$5.4M$16.5M$1.2M$418,470
Short-term investments———$0$933$933$18,723
Receivables$8,013$26,325$14,622$234,432$690,248$151,772$113,240
Inventory$0−$54,865−$14,622$100,339−$689,315$0$0
Other current assets$1.0M$478,022$526,178$2.2M$2.4M$439,496$427,884
Total current assets$12.0M$12.7M$578,594$7.9M$18.9M$1.8M$978,317
Property, plant & equipment (net)$3.1M$2.2M$2.9M$3.5M$4.0M$4.0M$4.2M
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$0$0$0$0$0$0$143,016
Total assets$15.1M$14.9M$3.5M$11.4M$22.9M$5.8M$5.3M
Liabilities
Accounts payable$2.0M$1.3M$5.2M$762,357$264,687$975,114$1.9M
Short-term debt$6.5M$2.7M$3.4M$5.4M$310,691$936,594$375,818
Deferred revenue————$601,300$1.2M$524,029
Total current liabilities$10.3M$5.0M$10.2M$7.0M$1.2M$3.4M$3.0M
Long-term debt$1.2M$2.4M$0$0$0$0$0
Lease obligations$1.3M$135,092$510,241$526,288$881,133$1.8M$2.2M
Other long-term liabilities$1.1M$0$135,099$510,235$866,037$1.1M$1.7M
Total liabilities$12.6M$7.4M$10.4M$7.5M$2.0M$4.5M$4.7M
Shareholders' equity
Common stock & paid-in capital$725$340$10$61$1,131$32.3M$615,848
Retained earnings (deficit)−$132.4M−$108.5M−$92.9M−$69.4M−$51.7M−$31.0M—
Accumulated other comprehensive income————$165$165$32
Total shareholders' equity$2.5M$7.5M−$6.9M$3.9M$20.8M$1.3M$615,880
Key figures
Total debt$8.8M$5.1M$3.5M$5.9M$1.2M$2.0M$2.1M
Net cash (debt)$2.2M$7.1M−$3.5M−$509,767$15.3M−$848,060−$1.7M
Working capital$1.7M$7.7M−$9.6M$856,852$17.7M−$1.6M−$2.0M
Tangible book value$2.5M$7.5M−$6.9M$3.9M$20.8M$1.3M$615,880
Book value per share$0.46$1.96—————
Shares outstanding5.4M3.8M—————
Current ratio1.162.550.061.1216.050.530.33
Quick ratio1.062.460.010.8014.600.400.19
Debt / equity3.500.68—1.510.061.583.39
Equity / assets16.6%50.2%−196.8%34.0%91.1%22.3%11.7%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 18, 2026); data from EODHD.

CING financial position

At the end of fiscal 2025 (December 31, 2025), Cingulate had total assets of $15.1 million (up 1.4% from a year earlier), total liabilities of $12.6 million and shareholders' equity of $2.5 million. It held $11.0 million in cash and short-term investments against $8.8 million of debt, a net cash position of $2.2 million. Its current ratio was 1.16. In the latest quarter (ended June 30, 2026) total assets were $33.1 million and equity $23.5 million.

Related: CING income statement, CING cash flow statement, CING key metrics. See the CING stock overview for the latest quote and news.

CING balance sheet FAQ

What are Cingulate's total assets?

Cingulate reported total assets of $15.1 million at the end of fiscal 2025 (December 31, 2025), compared with $14.9 million a year earlier.

How much debt does Cingulate have?

Cingulate had $8.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 3.50.

How much cash does Cingulate have?

Cingulate held $11.0 million in cash and short-term investments at the end of fiscal 2025; with $8.8 million of debt that is net cash of $2.2 million.

What is Cingulate's book value?

Cingulate's shareholders' equity (book value) was $2.5 million at the end of fiscal 2025, or $0.46 per share.

What is Cingulate's current ratio?

Cingulate had current assets of $12.0 million and current liabilities of $10.3 million, a current ratio of 1.16 (it can cover its short-term obligations).

Biotechnology: balance sheet